{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Alkenals", "Antioxidant response element", "Chronic Oxidative Stress", "Hydrogen peroxide", "Ozone"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "24600642", "DateCompleted": {"Year": "2014", "Month": "06", "Day": "16"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "21"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "2322-4436", "JournalIssue": {"Volume": "2", "Issue": "2", "PubDate": {"Year": "2013", "Season": "Summer"}}, "Title": "Medical hypothesis, discovery & innovation ophthalmology journal", "ISOAbbreviation": "Med Hypothesis Discov Innov Ophthalmol"}, "ArticleTitle": "Visual improvement following ozonetherapy in dry age related macular degeneration; a review.", "Pagination": {"StartPage": "47", "EndPage": "51", "MedlinePgn": "47-51"}, "Abstract": {"AbstractText": ["The dry form of ARMD is becoming a serious problem because of the rise in the number of old individuals. No effective therapy is available in dry ARMD except for the illusory oral administration of antioxidant vitamins. Despite scepticism in the medical community, the therapeutic effect of ozonetherapy had been evaluated since 1996. This evaluation has been based on specific biochemical, molecular and pharmacological reactions. Nevertheless a number of visual scientists continue to ignore ozonetherapy conservatively and prescribe only antioxidant vitamins. Two small clinical studies involving 217 patients have been performed at the University of Siena showing that ozonetherapy can stop the progression of the disease while improving the visual acuity and the well-being of the patient. Moreover, it seems that ozonetherapy is a safe procedure and tends to have an excellent compliance."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnologies, University of Siena, Italy."}], "LastName": "Borrelli", "ForeName": "Emma", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, University of Siena, Italy."}], "LastName": "Bocci", "ForeName": "Velio", "Initials": "V"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Med Hypothesis Discov Innov Ophthalmol", "NlmUniqueID": "101611331", "ISSNLinking": "2322-3219"}}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bocci V, Diadori A. \"Linee guida per alcune patologie oculari.\" . Rivista italiana di Oxsigeno-Ozonolerapia. 2003;2:59\u201361."}, {"Citation": "Bocci V. Ozone: a new medical drug. 2nd Edition. Dordrecht, The Netherlands: Springer Science+ Business Media; 2011. Retinal degenerative disorders; pp. 133\u2013145. s."}, {"Citation": "Borrelli E, Diadori A, Zalaffi A, Bocci V. Effects of major ozonated autohemotherapy in the treatment of dry age related macular degeneration: a randomized controlled clinical study. Int J Ophthalmol. 2012;5(6):708\u201313. PMID: 23275905.", "ArticleIdList": ["PMC3530813", "23275905"]}, {"Citation": "D'Amico DJ. Diseases of the retina. N Engl J Med. 1994 Jul;331(2):95\u2013106. Review. PMID: 8208273.", "ArticleIdList": ["8208273"]}, {"Citation": "Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA. 2004 Feb;291(6):704\u201310. PMID: 14871913.", "ArticleIdList": ["14871913"]}, {"Citation": "Evans JR. Risk factors for age-related macular degeneration. Prog Retin Eye Res. 2001 Mar;20(2):227\u201353. Review. PMID: 11173253.", "ArticleIdList": ["11173253"]}, {"Citation": "Bocci VA. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res. 2006 May;37(4):425\u201335. Review. PMID: 16624639.", "ArticleIdList": ["16624639"]}, {"Citation": "Bocci V. Is it true that ozone is always toxic? The end of a dogma. Toxicol Appl Pharmacol. 2006 Nov;216(3):493\u2013504. Epub 2006 Jun 27. Review. PMID:16890971.", "ArticleIdList": ["16890971"]}, {"Citation": "Bocci V, Borrelli E, Travagli V, Zanardi I. The ozone paradox: ozone is a strong oxidant as well as a medical drug. Med Res Rev. 2009 Jul;29(4):646\u201382. Review. PMID: 19260079.", "ArticleIdList": ["19260079"]}, {"Citation": "Bocci VA, Zanardi I, Travagli V. Ozone acting on human blood yields a hormetic dose-response relationship. J Transl Med. 2011 May;9:66. PMID: 21575276.", "ArticleIdList": ["PMC3125221", "21575276"]}, {"Citation": "Long EK, Picklo MJ Sr. Trans-4-hydroxy-2-hexenal, a product of n-3 fatty acid peroxidation: make some room HNE. Radic Biol Med. 2010 Jul;49(1):1\u20138. Review. PMID:20353821.", "ArticleIdList": ["20353821"]}, {"Citation": "Bocci V. Oxygen-Ozone Therapy: a critical evaluation. Dordrecht The Netherlands: Kluwer Academic Pub; 2002. pp. 1\u2013440."}, {"Citation": "Motohashi H, Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med. 2004 Nov;10(11):549\u201357. Review. PMID:15519281.", "ArticleIdList": ["15519281"]}, {"Citation": "Zhang DD. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev. 2006;38(4):769\u201389. Review. PMID: 17145701.", "ArticleIdList": ["17145701"]}, {"Citation": "Jung KA, Kwak MK. The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules. 2010 Oct;15(10):7266\u201391. Review. PMID: 20966874.", "ArticleIdList": ["PMC6259123", "20966874"]}, {"Citation": "Sagai M, Bocci V. Mechanisms of Action Involved in Ozone Therapy: Is healing induced via a mild oxidative stress? Med Gas Res. 2011 Dec;1:29. PMID: 22185664.", "ArticleIdList": ["PMC3298518", "22185664"]}, {"Citation": "Bocci V. How a calculated oxidative stress can yield multiple therapeutic effects. Free Radic Res. 2012 Sep;46(9):1068\u201375. PMID: 22583557.", "ArticleIdList": ["22583557"]}, {"Citation": "Pecorelli A, Bocci V, Acquaviva A, Belmonte G, Gardi C, Virgili F, Ciccoli L, Valacchi G. NRF2 activation is involved in ozonated human serum upregulation of HO-1 in endothelial cells. Toxicol Appl Pharmacol. 2013 Feb;267(1):30\u201340. PMID: 23253326.", "ArticleIdList": ["23253326"]}, {"Citation": "Krinsky NI, Landrum JT, Bone RA. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr. 2003;23:171\u2013201. Review. PMID: 12626691.", "ArticleIdList": ["12626691"]}], "ReferenceList": []}], "History": [{"Year": "2014", "Month": "3", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2014", "Month": "3", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2014", "Month": "3", "Day": "7", "Hour": "6", "Minute": "1"}, {"Year": "2013", "Month": "6", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["24600642", "PMC3939750"]}}], "PubmedBookArticle": []}